학술논문
Sustained and improved guselkumab response in patients with active psoriatic arthritis regardless of baseline demographic and disease characteristics: pooled results through week 52 of two phase III, randomised, placebo-controlled studies
Document Type
article
Author
Source
RMD Open, Vol 8, Iss 1 (2022)
Subject
Language
English
ISSN
2056-5933